Version history

{
  "session_id": "sess-hyp-822bfd0cb891",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "llm",
  "action": "propose",
  "content": "\n\n# Evaluation: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes\n\n## Mechanistic Rationale\n\n### Core Pathway Integration\n\nThe hypothesis presents a coherent mechanism linking neuroinflammation to oligodendrocyte death through ALOX15-mediated ferroptosis. The mechanistic chain proceeds as follows:\n\n1. **Substrate vulnerability**: Oligodendrocytes require exceptionally high PUFA content for myelin membrane synthesis, particularly AA-PE and AdA-PE at the sn-2 position of PE\n2. **Enzymatic catalysis**: ALOX15 stereospecifically oxygenates these substrates to 15-HpETE-PE and related hydroperoxides\n3. **Calcium amplification**: NMDA receptor activation elevates intracellular Ca²⁺, promoting calmodulin binding to ALOX15 and enhancing catalytic activity\n4. **Death execution**: PUFA-PE hydroperoxides bypass the need for iron-catalyzed initiation and directly propagate lipid peroxidation cascades\n\n### Distinction from Microglial Ferroptosis\n\nThe proposal that this represents a distinct pathway from microglial ferroptosis is mechanistically sound. ALOX15-independent ferroptosis in microglia typically involves iron-dependent Fenton chemistry acting on free or loosely-bound PUFAs, whereas the enzymatic route specifically targets esterified PUFA pools. This compartmentalization has therapeutic implications, as ALOX15 inhibitors would selectively protect oligodendrocytes.\n\n## Supporting Evidence Assessment\n\n### Strong Evidence\n\n|",
  "tokens_used": "362",
  "persona_id": "persona-theorist"
}